Discussion
In this study, we showed that IIH patients had thicker INL and ORL thicknesses than controls. When IIH eyes were stratified into eyes with and without ME, we showed that IIH eyes with ME had thicker INL and ORL thicknesses than eyes without ME and controls, respectively. In addition, IIH patients’ retinal sublayer thicknesses correlated with their ICP levels. Besides, ME in IIH patients was associated with higher ICP levels, more severe papilledema (measured by Frisen scores) and reduced VA.
The clinical use of subretinal thicknesses as a surrogate marker for IIH remains inconclusive, given the inconsistent findings between groups and various limitations associated with patients in OCT-based studies.19–22 These limitations include the difficulty for patients with papilledema and/or ME to cooperate with study protocols and the persistent challenge of diagnosing IIH clinically without ambiguity. Deviations in the reported results of macular RNFL and GCIPL in patients with IIH arise from intrinsic OCT apparatus variability including the eye tracking system, length of examination time, and resolution for adequately visualising the retina.16 23 Contrary to our previous report, we did not observe any significant differences in macular RNFL and GCIPL between IIH patients and controls due to different scanning areas.16 However, in our current study, when stratified into IIH eyes with or without ME, we showed that IIH eyes with ME had thicker RNFL thickness than controls or IIH eyes without ME, respectively. Here, we suggest that RNFL thickening in IIH eyes with ME may reflect axonal swelling due to capillary leakage and axoplasmic flow stasis, as previously reported.22
Previous studies predominantly focused on the inner subretinal thicknesses (RNFL and GCIPL) with less attention on the deeper structural thicknesses of the retina. In our current study, we showed that IIH patients had thicker INL and ORL thicknesses compared with controls. ME, a common clinical finding in IIH patients, is suggested to be associated with ocular glymphatic dysfunction,24 which affects the INL and ORL thicknesses. Here, we suggest that the thickening of the INL and ORL in IIH patients may be due to axoplasmic flow stasis (due to dysfunction of the retinal glymphatic system/haemostasis) as previously reported.2 25 Besides, we showed that the thickening of INL and ORL was more substantial in IIH eyes with ME than in IIH eyes without ME. It is plausible to suggest that fluid accumulation (ME) leads to ORL thickening.
Regarding the clinical utility of OCT metrics as a biomarker of ICP levels in IIH patients, previous studies suggested that changes in the retinal structural thicknesses (RNFL and GCIPL) may reflect the ICP levels in IIH patients.10 12 20 In our current study, we showed that RNFL and GCIPL thicknesses correlated with ICP levels in IIH patients, which was in line with prior studies.12 16 We also showed that INL and ORL thicknesses correlated with their ICP levels. The pathophysiology explanation for this observed association between the deeper structural thicknesses and the ICP levels in IIH patients is intriguing. Increased ICP is associated with papilledema, ultimately resulting in ME in the retina. Since the INL and ORL are associated with retinal haemostasis,24 our findings underpinning that changes in these retinal sublayer thicknesses are associated with ICP levels in IIH patients suggest that these layers may reflect the dysfunction of homeostasis coupled with increased ICP levels in IIH patients. Additionally, there were significant correlations between ICP levels and INL and ORL thicknesses in IIH eyes without ME; however, in IIH eyes with ME, there was no significant correlation between ICP and the thickness of INL and ORL. Given that the INL and ORL are sensitive to glymphatic changes in the retina, we suggest that these structural changes in IIH patients may be associated with their ICP levels before the occurrence of ME. Therefore, we highlight the need for clinicians to pay attention to the assessment of the INL and ORL thicknesses in the assessment of the retina to prevent ME and further complications.
In the retina, ME is considered to be due to extravascular accumulation of proteins and lipids.26 27 In IIH patients, it is suggested that ME is a result of papilledema7; IIH eyes with ME had higher ICP levels and worse papilledema. Many of the retinal changes seem to be directly proportional to papilledema severity. Here, we suggest that changes in ICP levels may cause papilledema (venous congestion and capillary leakage) which may ultimately lead to ME in the retina. Of note, we showed that IIH eyes with ME had reduced VA compared with eyes without ME. Previous studies demonstrated that ME results in reduced VA, which is in line with our findings.26–28 Taken together, our findings highlight the need for clinicians to prioritise ME assessment for timely intervention to improve the prognosis for IIH patients.
The strengths of this study are the relatively large sample of patients with confirmed IIH and analyses of both eyes per participant with fundus photography and OCT. Detection of ME was confirmed by fundus photography and a comprehensive structural imaging protocol that generated intra-retinal thickness metrics describing each layer of the retina was done automatically by the OCT tool.
Our study has some limitations. The observational, cross-sectional design of this study does not allow for inferences regarding the causal mechanisms between retinal changes, VA and ME in IIH patients. To address this limitation, we have initiated a longitudinal study to explore the mechanisms underlying retinal changes associated with visual changes, retinopathy signs such as ME and ICP. We did not assess retinal vessels in our study. Moreover, participants with ocular abnormalities and patients with severe papilledema and ME (detachment of the ORL) were excluded, which might introduce selection bias. We did not perform visual field examinations for all IIH patients in our study. Analysis of visual field, ME and OCT features will be more precise to explore their relationship.
The results of this comprehensive study highlight those changes of retinal thickness (especially the deeper layers, INL and ORL) are correlated with ME. We also showed that in IIH patients, INL and ORL thickness was correlated with ICP levels. Importantly, we showed that ME was associated with higher ICP, worse papilledema and impaired VA. Patients with IIH may benefit from OCT for detecting ME and retinal structure changes. Future prospective longitudinal studies are needed to determine whether ME can be used as a surrogate marker for IIH patients.